Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
$6,304.00
$0.00
$0.00
N/AN/AN/A8,370 shs
Axel Springer SE stock logo
AXELF
Axel Springer
$79.57
$79.57
$79.57
$79.57
N/AN/A400 shsN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
$0.35
+6.1%
$0.31
$0.23
$2.08
$2.11M0.2350,878 shs1.31 million shs
Legg Mason, Inc. stock logo
LM
Legg Mason
$49.99
$49.99
$33.99
$50.70
$4.45B0.732.34 million shs4.72 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
0.00%0.00%0.00%0.00%0.00%
Axel Springer SE stock logo
AXELF
Axel Springer
0.00%0.00%0.00%0.00%0.00%
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
+1.14%+23.30%+13.50%-18.41%-76.49%
Legg Mason, Inc. stock logo
LM
Legg Mason
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/AN/AN/AN/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/AN/AN/AN/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Legg Mason, Inc. stock logo
LM
Legg Mason
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
N/AN/AN/AN/A
Legg Mason, Inc. stock logo
LM
Legg Mason
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/AN/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/AN/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
$4.14M0.51N/AN/A$1.83 per share0.19
Legg Mason, Inc. stock logo
LM
Legg Mason
$2.92B1.52$4.63 per share10.80$43.40 per share1.15

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/AN/A0.00N/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
-$7.95MN/A0.00N/A-108.02%-53.42%-45.36%10/4/2024 (Estimated)
Legg Mason, Inc. stock logo
LM
Legg Mason
$251.37M$3.7617.7913.965.298.86%8.87%4.24%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
N/AN/AN/AN/AN/A
Legg Mason, Inc. stock logo
LM
Legg Mason
$1.603.20%N/A42.55%N/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
0.07
6.58
5.80
Legg Mason, Inc. stock logo
LM
Legg Mason
0.59
2.20
1.71

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/A
Axel Springer SE stock logo
AXELF
Axel Springer
N/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
20.12%
Legg Mason, Inc. stock logo
LM
Legg Mason
92.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/ANot Optionable
Axel Springer SE stock logo
AXELF
Axel Springer
16,120N/AN/ANot Optionable
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
136.06 million5.97 millionNot Optionable
Legg Mason, Inc. stock logo
LM
Legg Mason
3,05988.95 millionN/AOptionable

INM, LM, TNI, ASP, and AXELF Headlines

Recent News About These Companies

French Bank Fined $1 Billion for Bribes in Libya
Legg Mason Western Asset Aus B (SSB0122AU.AX)
Legg Mason WA US High Yield LM Acc $ (IE00B23Z9M03.IR)
Australian Unity Office Fund Registered Shs
Odesnik advances at Legg Mason
Mason Mount News

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Strategic Income Portfolio logo

American Strategic Income Portfolio

NYSE:ASP
American Strategic Income Portfolio Inc. (ASP) invests in mortgage-related assets that directly or indirectly represent a participation in or are secured by and payable from mortgage loans. The Fund may also invest in the United States Government securities, corporate debt securities, preferred stock issued by real estate investment trusts, and mortgage servicing rights. In addition, the Fund may borrow using reverse repurchase agreements and credit facilities. The Fund's primary objective is to achieve high levels of current income. Its secondary objective is to seek capital appreciation. The Barclays Capital Mutual Fund Government/Mortgage Index, ASP's benchmark, consists of all the United States Government agency and Treasury securities and agency mortgage-backed securities. The Fund's investment advisor is U.S. Bancorp Asset Management, Inc. ASP's sub-advisors include Nuveen Asset Management, LLC and Nuveen Fund Advisors, Inc.
Axel Springer logo

Axel Springer

OTCMKTS:AXELF
Axel Springer SE operates as a publishing company primarily in Europe and the United States. The company operates through three segments: Classifieds Media, News Media, and Marketing Media. The Classifieds Media segment operates a portfolio of online classified portals in the areas of real estate, jobs, cars, and general. This segment operates SeLoger, Immoweb, and Immowelt/Immonet real estate portals; Totaljobs, Jobsite, and Saongroup job portals; meinestadt.de, a regional portal; and car and general classified ad portals, including LaCentrale and Yad2. The News Media segment offers newspapers primarily under the BILD and WELT brands in Berlin, as well as the FAKT name in Poland; automotive, computer, and sports magazines under the AUTO BILD, COMPUTER BILD, and SPORT BILD brand names; and a tabloid under the BLIKK name in Hungary. This segment also operates Internet portals, such as Onet.pl and azet.sk; profession.hu, a job portal; WELT, a news channel; BILD.de, a news and entertainment portal; WELT.de, a news portal; Upday, a mobile news portal; businessinsider.com; and Autobild.de, a digital appearances of the magazine. Its digital offerings also comprise analytics, studies, and digital market data for companies and institutions. The Marketing Media segment provides advertising services on performance or reach based marketing. The company distributes its print media primarily through press wholesale companies, station book trade, and press import companies; and digital products principally through its webpages or download platforms, including the app stores of Apple and Google. Axel Springer SE was founded in 1946 and is headquartered in Berlin, Germany.
InMed Pharmaceuticals logo

InMed Pharmaceuticals

NASDAQ:INM
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Legg Mason logo

Legg Mason

NYSE:LM
Legg Mason, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides investment management and related services to company-sponsored mutual funds and other investment vehicles including pension funds, foundations, endowments, sovereign wealth funds, insurance companies, private banks, family offices, individuals, as well as to global, institutional, and retail clients. It launches and manages equity, fixed income, and multi-asset customized portfolios through its subsidiaries. The firm also launches and manages mutual funds and exchange traded funds for its clients through its subsidiaries. It invests in private and public equity, fixed income, and multi asset markets across the globe through its subsidiaries. Through its subsidiaries, the firm also invests in alternative markets. It also employs a combination of fundamental and quantitative research to make its investments through its subsidiaries. Legg Mason, Inc. was founded in 1899 and is based in Baltimore, Maryland.